Colorectal cancer and preventative screening legislation in the US

Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation’s National Colorectal Cancer Research Alliance (EIF’s NCCRA) and the American Gastroenterological Association (AGA).

Colorectal cancer is the second-leading cancer killer; however fewer states have passed preventative screening legislation for this disease than for other cancers with lower death rates. For instance, guaranteed insurance coverage laws exist in 47 states for breast cancer screenings; 26 states for prostate cancer; and 23 states for cervical cancer. Despite the fact that 90 percent of colorectal cancers are curable with early detection, the disease accounts for 56,000 deaths every year in the United States.

“For many people a major obstacle in getting tested is the uncertainty of whether or not their insurance covers the cost of comprehensive colorectal cancer screenings,” says Lisa Paulsen, president and CEO of the Entertainment Industry Foundation. “EIF’s National Colorectal Cancer Research Alliance has teamed up with AGA to clearly explain state laws and reinforce the importance of preventative screenings as the first step to beating colorectal cancer.”

The 2004 Colorectal Cancer Screening Legislation Report Card is a comprehensive analysis of the varied and complex state laws governing insurance coverage for preventative colorectal cancer screenings. EIF’s NCCRA and AGA encourage states without legislation to take action. The full report is available at


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?